<DOC>
	<DOCNO>NCT02894905</DOCNO>
	<brief_summary>The purpose study evaluate pharmacokinetics ( PK ) single oral dose AL-335 participant various degree impair renal function ( mild , moderate , severe ) compare participant normal renal function .</brief_summary>
	<brief_title>A Study Evaluate Effect Renal Impairment Pharmacokinetics AL-335</brief_title>
	<detailed_description />
	<mesh_term>Renal Insufficiency</mesh_term>
	<criteria>Cohorts 14 : Participant must body mass index ( BMI ; weight kilogram ( kg ) divide square height meter ) 18 36 kilogram per meter square ( kg/m^2 ) , extremes include , body weight less 50.0 kg Participants must agree follow requirement must meet study note Inclusion Exclusion Criteria ( eg , contraceptive requirement ) Female participant must agree donate egg ( ovum , oocytes ) purpose assist reproduction study period 30 day study drug administration Male participant must agree donate sperm enrollment ( Day 1 ) study least 30 day receive study drug Cohorts 13 : Participant must stable renal function Participant must otherwise healthy except renal impairment underlie disease state mild comorbidities participant must medically stable basis physical examination , medical history , vital sign , 12lead electrocardiogram ( ECG ) , clinical laboratory test perform screen Participants must estimate glomerular filtration rate ( eGFR ) less ( &lt; ) 90 milliLiter per minute per 1.73 meter square ( mL/min/1.73m^2 ) . Mild renal impairment ( eGFR 60 &lt; 90 mL/min/1.73m^2 ) ; moderate renal impairment ( eGFR 30 &lt; 60 mL/min/1.73m^2 ) ; severe renal impairment ( eGFR &lt; 30 mL/min/1.73m^2 require dialysis ) Cohort 4 : Participant must healthy basis physical examination , medical history , vital sign , 12lead ECG , clinical laboratory test perform screen Participants must eGFR great equal ( &gt; = ) 90 mL/min/1.73m^2 Cohorts 14 : Participant history illness ( unrelated renal impairment underlie disease , appropriate ) , opinion investigator , might confound result study pose additional risk administer study drug participant . This may include limited history relevant drug food allergy , history cardiovascular central nervous system disease , history presence clinically significant pathology , chronic skin disease , history mental disease Participant vegetarian diet take creatine supplement , nonstandard muscle mass , example ( eg ) , amputation , malnutrition , muscle wasting , extremely muscular ( body building ) Participant history hepatitis B surface antigen ( HBsAg ) hepatitis C antibody ( anti HCV ) positive , clinically active liver disease , test positive HBsAg antiHCV screen Participant history human immunodeficiency virus ( HIV ) antibody positive , test positive HIV screening Participant smoke 10 cigarette 2 cigar 2 pipe per day within 3 month screen end study Participant woman pregnant , breastfeeding , plan become pregnant signing Informed Consent Form ( ICF ) onwards 30 day study drug administration Participant man plan father child enrol study ( Day 1 ) 30 day study drug administration . Cohorts 13 : Participant require dialysis Participant imminent renal replacement therapy ( ie , study period )</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>75 Years</maximum_age>
	<verification_date>March 2017</verification_date>
</DOC>